Elevation of Aminotransferases and Total Bilirubin Levels as Prognostic Markers of Mortality in Adults Hospitalized for COVID-19. A Cohort Study

Abstract

<i>Elevated transaminases and total bilirubin levels are frequent findings in patients with COVID-19 and hypoxemia. Aspartate aminotransferase and total bilirrubin were predictive of mortality in these patients, so their measurement on admission is a reasonable practice. Progress needs to be made in incorporating these markers into predictive models of mortality and clinical decision rules.</i>